These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7040419)

  • 1. Sources and biology of regulatory factors active on mouse myeloid leukemic cells.
    Metcalf D
    J Cell Physiol Suppl; 1982; 1():175-83. PubMed ID: 7040419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a serum factor stimulating the differentiation of myelomonocytic leukemic cells.
    Burgess AW; Metcalf D
    Int J Cancer; 1980 Nov; 26(5):647-54. PubMed ID: 6972358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal extinction of myelomonocytic leukemic cells by serum from mice injected with endotoxin.
    Metcalf D
    Int J Cancer; 1980 Feb; 25(2):225-33. PubMed ID: 6967053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis by mouse peritoneal cells of G-CSF, the differentiation inducer for myeloid leukemia cells: stimulation by endotoxin, M-CSF and multi-CSF.
    Metcalf D; Nicola NA
    Leuk Res; 1985; 9(1):35-50. PubMed ID: 3887043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-CSF: its relationship to leukemia differentiation-inducing activity and other hemopoietic regulators.
    Moore MA
    J Cell Physiol Suppl; 1982; 1():53-64. PubMed ID: 6802860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
    Ling X; Wang Y; Dietrich MF; Andreeff M; Arlinghaus RB
    Oncogene; 2006 Jul; 25(32):4483-90. PubMed ID: 16547503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulator-induced suppression of myelomonocytic leukemic cells: clonal analysis of early cellular events.
    Metcalf D
    Int J Cancer; 1982 Aug; 30(2):203-10. PubMed ID: 6982238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal analysis of the action of GM-CSF on the proliferation and differentiation of myelomonocytic leukemic cells.
    Metcalf D
    Int J Cancer; 1979 Nov; 24(5):616-23. PubMed ID: 316807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of normal differentiation of myeloid leukemic cells. IV. Induction of differentiation by serum from endotoxin treated mice.
    Fibach E; Sachs L
    J Cell Physiol; 1974 Apr; 83(2):177-85. PubMed ID: 4595662
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoinduction of differentiation in WEHI-3B leukemia cells.
    Metcalf D; Nicola NA
    Int J Cancer; 1982 Dec; 30(6):773-80. PubMed ID: 6984432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of in vivo differentiation of myeloid leukemic cells. III. Regulation by T lymphocytes and inflammation.
    Lotem J; Sachs L
    Int J Cancer; 1983 Dec; 32(6):781-91. PubMed ID: 6606629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of differentiation in murine myelomonocytic leukemia cells by the serum of patients with acute myeloid leukemia and other diseases.
    Metcalf D
    Int J Cancer; 1981 May; 27(5):577-84. PubMed ID: 6945296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic implications of serum factors inhibiting proliferation and inducing differentiation of myeloid leukemic cells.
    Moore MA; Gabrilove J; Sheridan AP
    Blood Cells; 1983; 9(1):125-44. PubMed ID: 6602636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical properties of differentiation factors for murine myelomonocytic leukemic cells in organ conditioned media--separation from colony-stimulating factors.
    Nicola NA; Metcalf D
    J Cell Physiol; 1981 Nov; 109(2):253-64. PubMed ID: 6975280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and functional characterization of mature progeny purified from a myelomonocytic leukemia cell line.
    Cooper PC; Metcalf D; Burgess AW
    Leuk Res; 1982; 6(3):313-27. PubMed ID: 6956783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The production of differentiation autoinducing activity by WEHI-3B D+ leukemia cells.
    Kajigaya Y; Ikuta K; Sasaki H; Funabiki T; Koiso Y; Matsuyama S
    Exp Hematol; 1989 May; 17(4):368-73. PubMed ID: 2785052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a lacZ marked WEHI-3B D+ murine leukemic cell line as an in-vivo model of acute non-lymphocytic leukemia.
    Smith C; Muench MO; Knizewski M; Gilboa E; Moore MA
    Leukemia; 1993 Feb; 7(2):310-7. PubMed ID: 8426483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colony stimulating and inhibiting activities in mouse serum after Corynebacterium parvum-endotoxin treatment.
    Shah RG; Green S; Moore MA
    J Reticuloendothel Soc; 1978 Jan; 23(1):29-41. PubMed ID: 304892
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of hemopoietic growth factors from T cells and the myelomonocytic leukemia WEHI-3B.
    Clark-Lewis I; Thomas WR; Schrader JW
    Exp Hematol; 1985 May; 13(4):304-11. PubMed ID: 3921392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WEHI-3B D+ Y1 leukemia cells as a model system to assess the induction of differentiation in vivo.
    Gamba-Vitalo C; Carman MD; Sartorelli AC
    Cancer Commun; 1989; 1(3):157-65. PubMed ID: 2561737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.